DUBLIN–(BUSINESS WIRE)–The “Comprehensive Metabolic Panel Testing Market Size, Share & Trends Analysis Report By Analytes (K+, Na+, Cl-, CO2, Glucose), By Disease, By End-use (Laboratory, PoC), By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.
The global comprehensive metabolic panel testing market size is expected to reach USD 20.87 billion by 2030
The market is expected to expand at a CAGR of 9.1% from 2023 to 2030. The market driven by an increasing global disease burden and the emergence of novel diagnostic products.
Rising prevalence of chronic diseases coupled with increasing need to curb healthcare expenditure are expected to boost the CMP testing market by increasing the demand for early disease diagnosis and regular monitoring. Introduction of technologically advanced products, such as biochips, microarrays, and companion diagnostics, has driven the necessity for early detection of anomalies. CMP testing offers a cost-effective and time-saving method for evaluating 14 analytes for identification, diagnosis, or monitoring of several diseases.
Rising consumer awareness regarding healthcare is one of the major factors anticipated to drive the market for CMP testing. Many organizations worldwide are working toward increasing awareness pertaining to diseases, available treatment options, and benefits of early diagnosis and precautions. For instance, the International Diabetes Foundation and the American Diabetes Association are some of the key organizations that emphasize the urgent need for diagnosing and monitoring diabetes through several awareness campaigns and other modes of advertisement.
The buying behavior of consumers is moderately complex in the comprehensive metabolic panel testing market, due to subtle differences in product prices. The products offered by various market players have been strategically priced to increase competitive rivalry. As the market becomes increasingly competitive, consumer needs are anticipated to reach at an all-time high for improved diagnostics – in terms of safety, efficacy, sensitivity, and specificity.
The medical diagnostics landscape has undergone a paradigm shift over the last few years, driven by the launch of improved diagnostic products and introduction of biomarkers. However, recurrence and disease progression remain high, especially among geriatric patients. Strong unmet needs present a key opportunity to develop breakthrough first-in-class diagnostics in the CMP testing space.
Comprehensive Metabolic Panel Testing Market Report Highlights
- The kidney diseases segment accounted for the largest revenue share of 32.71% in 2022, and the segment is driven by a high disease prevalence and maximum utilization of analytes.
- The diabetes segment is expected to grow at the fastest CAGR of 9.9% during the forecast period. Nearly 50% of diabetics remain undiagnosed, presenting a lucrative opportunity for growth for the comprehensive metabolic panel testing market.
- The PoC segment is expected to grow at the fastest CAGR of 9.8% over the forecast period. The PoC CMP tests are driven by their ease of operation, portability, speed of results, and lesser requirement of the sample.
- The laboratories segment accounted for the highest revenue share of 59.97% in 2022, driven by easy availability, high market penetration, increased usage, and clinically significant results.
- Asia Pacific is expected to grow at the highest CAGR of 11.7% over the forecast period, driven by improvements in healthcare infrastructure, a rise in the number of older people, who are more susceptible to chronic illnesses, growth in consumer awareness, a rise in disposable income, and overall economic development.
Company Profiles
- Abbott
- Quest Diagnostics
- Laboratory Corporation of America Holdings
- Sonic Healthcare Limited
- Unipath
- SYNLAB International GmbH
- ARUP Laboratories
- Genoptix Inc.
- Nova Biomedical
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 100 |
| Forecast Period | 2022 – 2030 |
| Estimated Market Value (USD) in 2022 | $10.19 Billion |
| Forecasted Market Value (USD) by 2030 | $20.87 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Comprehensive Metabolic Panel Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Comprehensive Metabolic Panel Testing Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.2. PESTEL Analysis
Chapter 4. Comprehensive Metabolic Panel Testing Market: Analytes Estimates & Trend Analysis
4.1. Comprehensive Metabolic Panel Testing Market: Key Takeaways
4.2. Comprehensive Metabolic Panel Testing Market: Movement & Market Share Analysis, 2022 & 2030
4.3. K+
4.3.1. K+ market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Na+
4.5. Cl-
4.6. CO2
4.7. Glucose
4.8. BUN
4.9. Creatinine
4.10. Ca++
4.11. Albumin
4.12. Total Protein
4.13. ALP
4.14. ALT
4.15. AST
4.16. Total Bilirubin
Chapter 5. Comprehensive Metabolic Panel Testing Market: Disease Estimates & Trend Analysis
5.1. Comprehensive Metabolic Panel Testing Market: Key Takeaways
5.2. Comprehensive Metabolic Panel Testing Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Kidney Diseases
5.4. Liver Diseases
5.5. Diabetes
Chapter 6. Comprehensive Metabolic Panel Testing Market: End-Use Estimates & Trend Analysis
6.1. Comprehensive Metabolic Panel Testing Market: Key Takeaways
6.2. Comprehensive Metabolic Panel Testing Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Laboratories
6.3.1. Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.2. Emergency departments
6.3.3. Hospital wards
6.3.4. Primary care
6.3.5. Pharmacy
6.3.6. Telemedicine
6.4. PoC
6.4.1. PoC market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.2. Emergency departments
6.4.3. Hospital wards
6.4.4. Primary care
6.4.5. Pharmacy
6.4.6. Telemedicine
6.5. PoC (Instruments)
6.5.1. PoC market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.2. Piccolo Xpress
6.5.3. Skyla-HB1
6.5.4. DRI-CHEM NX500
Chapter 7. Comprehensive Metabolic Panel Testing Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Comprehensive Metabolic Panel Testing Market by Region: Key Marketplace Takeaway
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. Company overview
8.2.2. Financial performance
8.2.3. Product benchmarking
8.2.4. Strategic initiatives
For more information about this report visit https://www.researchandmarkets.com/r/sb7t7y
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
